TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM NEW
Total 13F shares
3,466,822
Share change
+394,974
Total reported value
$51,245,000
Price per share
$14.78
Number of holders
31
Value change
+$5,994,500
Number of buys
16
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q3 2016

As of 30 Sep 2016, TRILLIUM THERAPEUTICS INC - COM NEW was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,466,822 shares. The largest 10 holders included JANUS CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, Point72 Asset Management, L.P., venBio Select Advisor LLC, EverPoint Asset Management, LLC, Opaleye Management Inc., DEERFIELD MANAGEMENT CO, Private Capital Advisors, Inc., and SPHERA FUNDS MANAGEMENT LTD.. This page lists 31 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.